Prevalence of Rifampicin Resistance in Pediatric Patients with Mycobacterium Tuberculosis Using Gene Expert in Gulab Devi Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i7.2004Keywords:
Pediatric Tuberculosis, Rifampicin Resistance, GeneXpert, Xpert MTB/RIF Assay, Malnourishment, Cross-sectional StudyAbstract
Background: The prevalence of rifampicin resistance in pediatric patients with Mycobacterium tuberculosis is a growing concern, particularly in regions with high TB burden. Early and accurate detection of drug resistance is crucial for effective treatment and management, especially in children who are more vulnerable to complications. Objective: This study aims to assess prevalence of rifampicin resistance in pediatric patients with mycobacterium tuberculosis using gene expert in gulab devi hospital. Methods: The study was conducted at the Department of Paediatrics at Gulab Devi Hospital Lahore, using a cross-sectional design over a period of six months. A total of 150 pediatric patients, selected through non-probability consecutive sampling, were included based on the inclusion criteria, including newly diagnosed MTB cases. Sputum or gastric lavage samples were collected and processed using the Xpert MTB/RIF assay for the diagnosis of tuberculosis and detection of rifampicin resistance. Results: The mean age of the participants was 10.51 years, with a standard deviation of 2.692 years. The gender distribution was relatively balanced, with 47.3% male and 52.7% female participants. Regarding rifampicin resistance, 8.0% of the participants exhibited rifampicin resistance. Conclusion: The study demonstrated a relatively low prevalence of rifampicin resistance (8.0%) in pediatric patients with Mycobacterium tuberculosis as detected by GeneXpert.
Downloads
References
1. Gough, A. (2011). Pulmonary tuberculosis: Clinical features and patient management. Nursing Standard, 25(47), 48-58.
https://doi.org/10.7748/ns.25.47.48.s51
2. Martinez, L., Cords, O., Horsburgh, C. R., Andrews, J. R., Acuna-Villaorduna, C., Ahuja, S. D., ... & Zhu, L. (2020). The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. The Lancet, 395(10228), 973-984.
3. Farah, M. G., Rygh, J. H., Steen, T. W., Selmer, R., Heldal, E., & Bjune, G. (2006). Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infectious Diseases, 6(1).
https://doi.org/10.1186/1471-2334-6-33
4. WHO, G. (2020). Global tuberculosis report 2020. Glob. Tuberc. Rep, 2020.
5. Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D., Bulabula, A. N., Sam-Agudu, N. A., Nachega, J. B., Tiberi, S., McHugh, T. D., Abubakar, I., & Zumla, A. (2021). Global tuberculosis report 2020 – Reflections on the global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases, 113, S7-S12.
https://doi.org/10.1016/j.ijid.2021.02.107
6. Zhang, C., Wang, Y., Shi, G., Han, W., Zhao, H., Zhang, H., & Xi, X. (2015). Determinants of multidrug-resistant tuberculosis in Henan province in China: A case control study. BMC Public Health, 16(1).
https://doi.org/10.1186/s12889-016-2711-z
7. Khan, A. A., Khan, H. U., Khan, Z., Khan, I., Rahim, A., Rahman, A. U., Ur-Rehman, Q. N., Roman, M., & Sajjad, M. (2022). Prevalence of rifampicin resistance and probes identification of 81bp rrdr rpo-B gene in pulmonary tuberculosis patients of district bannu, Pakistan. Gomal Journal of Medical Sciences, 20(2), 75-81.
https://doi.org/10.46903/gjms/20.02.1122
8. Pandey, P., Pant, N. D., Rijal, K. R., Shrestha, B., Kattel, S., Banjara, M. R., Maharjan, B., & KC, R. (2017). Diagnostic accuracy of GeneXpert MTB/RIF assay in comparison to conventional drug susceptibility testing method for the diagnosis of multidrug-resistant tuberculosis. PLOS ONE, 12(1), e0169798.
https://doi.org/10.1371/journal.pone.0169798
9. Atashi, S., Izadi, B., Jalilian, S., Madani, S., Farahani, A., & Mohajeri, P. (2017). Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran. New Microbes and New Infections, 19, 117-120.
https://doi.org/10.1016/j.nmni.2017.07.002
10. How, S. H., Kuan, Y. C., Ng, T. H., Razali, M. R., & Fauzi, A. R. (2014). Monitoring treatment response in sputum smear positive pulmonary tuberculosis patients: comparison of weight gain, sputum conversion and chest radiograph. PubMed, 36(2), 91–96.
11. Dejene, T., Hailu, G., Kahsay, A., & Wasihun, A. (2023). Pulmonary tuberculosis and Rifampicin resistant mycobacterium tuberculosis in children and adolescents using gene Xpert MTB/RIF assay in Tigray, northern Ethiopia. Infection and Drug Resistance, 16, 6757-6765.
https://doi.org/10.2147/idr.s433789
12. Kumar, R., Sood, A. K., Bajaj, M., & Kanga, A. (2019). Utility of GeneXpert for detection of mycobacterium tuberculosis and Rifampicin resistance in pediatric tuberculosis. Pediatric Infectious Disease, 1(4), 137-141.
https://doi.org/10.5005/jp-journals-10081-1229
13. Jameel, R., Mehdi, N., Majeed, N., Zafar, A., Tahir, A., & Aroob, I. (2024). Prevalence and diagnosis of rifampicin-resistant mycobacterium tuberculosis using the GeneXpert MTB/RIF assay at a tertiary care Children's Hospital. Pakistan Journal of Health Sciences, 110-114.
https://doi.org/10.54393/pjhs.v5i07.1764
14. Ramachandra, V., Brammacharry, U., Muralidhar, A., Muthukumar, A., Mani, R., Muthaiah, M., Soundappan, G., & Frederick, A. (2023). Assess the Diagnostic Accuracy of GeneXpert to Detect Mycobacterium tuberculosis and Rifampicin-Resistant Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis Patients. Microbiology Research, 15(1), 91–108.
https://doi.org/10.3390/microbiolres15010006
15. WİLLİAM, A., RAI, Y., & KAUR, R. (2021). Evaluation of Rifampicin-resistant Tuberculosis in Pediatric Patients by GeneXpert MTB/RIF. Journal of Microbiology and Infectious Diseases, 11(02), 81–87.
https://doi.org/10.5799/jmid.951506
16. Sajid, A., & Riaz, S. (2018). ROLE OF GENE EXPERT/MTB TEST IN CHILDHOOD TUBERCULOSIS. DOAJ (DOAJ: Directory of Open Access Journals), 9(3), 1–5.
17. Dejene, T., Hailu, G., Kahsay, A., & Wasihun, A. (2023). Pulmonary Tuberculosis and Rifampicin Resistant Mycobacterium Tuberculosis in Children and Adolescents using Gene Xpert MTB/RIF Assay in Tigray, Northern Ethiopia. Infection and Drug Resistance, Volume 16, 6757–6765.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
